Screening for pancreatic cancer in a high-risk cohort: an eight-year experience. (Q51173711)

31 March 2018

title

Screening for pancreatic cancer in a high-risk cohort: an eight-year experience. (English)

1 reference

31 March 2018

1 reference

9

Steven Narod

1 reference

31 March 2018

12

Steven Gallinger

1 reference

31 March 2018

author name string

Wigdan Al-Sukhni

1

1 reference

31 March 2018

Ayelet Borgida

2

1 reference

31 March 2018

Heidi Rothenmund

3

1 reference

31 March 2018

Spring Holter

4

1 reference

31 March 2018

Kara Semotiuk

5

1 reference

31 March 2018

Robert Grant

6

1 reference

31 March 2018

Stephanie Wilson

7

1 reference

31 March 2018

Malcolm Moore

8

1 reference

31 March 2018

Kartik Jhaveri

10

1 reference

31 March 2018

Masoom A Haider

11

1 reference

31 March 2018

publication date

30 November 2011

1 reference

31 March 2018

Journal of Gastrointestinal Surgery

published in

1 reference

31 March 2018

volume

16

1 reference

31 March 2018

issue

4

1 reference

31 March 2018

page(s)

771-783

1 reference

31 March 2018

https://scigraph.springernature.com/pub.10.1007/s11605-011-1781-6

exact match

0 references

cites work

Metastatic pancreatic cancer: is gemcitabine still the best standard treatment? (Review).

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1781-6

Clinical aspects of intraductal papillary mucinous neoplasm of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1781-6

Incidence of synchronous and metachronous pancreatic carcinoma in 168 patients with branch duct intraductal papillary mucinous neoplasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1781-6

Prognosis of cancer with branch duct type IPMN of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1781-6

Increased Risk of Pancreatic Cancer in Melanoma-Prone Kindreds withp16INK4Mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1781-6

Increased Risk of Cancer Other Than Melanoma in CDKN2A Founder Mutation (p16-Leiden)-Positive Melanoma Families

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1781-6

Very high risk of cancer in familial Peutz-Jeghers syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1781-6

Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1781-6

Cancer risks in BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1781-6

Cancer risks in BRCA2 families: estimates for sites other than breast and ovary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1781-6

Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1781-6

A population-based description of familial clustering of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1781-6

Importance of age of onset in pancreatic cancer kindreds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1781-6

Family history of cancer and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1781-6

Advances in counselling and surveillance of patients at risk for pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1781-6

Allergies are associated with reduced pancreas cancer risk: A population-based case-control study in Ontario, Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1781-6

Risk of pancreatic cancer among individuals with a family history of cancer of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1781-6

PancPRO: risk assessment for individuals with a family history of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1781-6

Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1781-6

Magnetic resonance imaging surveillance detects early-stage pancreatic cancer in carriers of a p16-Leiden mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1781-6

Feasibility and yield of screening in relatives from familial pancreatic cancer families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1781-6

Magnetic resonance imaging of cystic and endocrine pancreatic neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1781-6

Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1781-6

Pancreatic intraepithelial neoplasia revisited and updated

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1781-6

Incidence, prevalence, and management of intraductal papillary mucinous neoplasm in Olmsted County, Minnesota, 1984-2005: a population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1781-6

High prevalence of pancreatic cysts detected by screening magnetic resonance imaging examinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1781-6

Distant metastasis occurs late during the genetic evolution of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1781-6

The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer

21 January 2018

1 reference

12 December 2020

Pancreatic cancer screening in a prospective cohort of high-risk patients: a comprehensive strategy of imaging and genetics

1 reference

12 December 2020

Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer

1 reference

12 December 2020

Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer

1 reference

12 December 2020

Identification and screening of individuals at increased risk for pancreatic cancer with emphasis on known environmental and genetic factors and hereditary syndromes

1 reference

12 December 2020

Should patients with a strong family history of pancreatic cancer be screened on a periodic basis for cancer of the pancreas?

1 reference

12 December 2020

Update on familial pancreatic cancer

1 reference

12 December 2020

Natural history of branch duct intraductal papillary-mucinous neoplasms of the pancreas without mural nodules: long-term follow-up results

1 reference

12 December 2020

Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer.

1 reference

12 December 2020

Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds

1 reference

12 December 2020

10.1007/S11605-011-1781-6

Identifiers

DOI

1 reference

31 March 2018

PubMed ID

22127781

1 reference

31 March 2018